Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by love_minus_zeroon Nov 12, 2010 5:29am

422 Views

Post# 17697013

RE: 12M target

Immo, I am expecting a new review and target from BMO very soon (perhaps today).
In the next few days (it would be fantastic if it was today...get that IR FOLKS...) expect another partner(s) to be announced.
Also, even though no one is calling for it to happen...it remains in the realm of the possible for Merck to just take us out.
And I'll let them!
After this program of foreverness (to get approved) it is my expectation that management reward us with a seemless, swift and flawless roll out.
Make it happen TH.
lmz

Bullboard Posts

This junior mining stock offers billions in market exposure